Â鶹´«Ã½¸ßÇå°æ

Thangamani Muthukumar, M.D., M.S., is an Associate Professor of Medicine at the Weill Cornell Medical College and the Associate Director for the Nephrology Fellowship Program at Weill Cornell. He trained as a nephrologist in India and again in the U.S.A. He graduated from the Madras Medical College, Chennai (Madras), India and after residency in medicine, completed his nephrology fellowship at the Post Graduate Institute of Medical Education and Research, Chandigarh, India. He was a research fellow at Cornell, in the transplantation immunology research laboratory of Dr. Manikkam Suthanthiran, Stanton Griffis Distinguished Professor of Medicine. Dr. Muthukumar subsequently repeated his residency in medicine and fellowship in nephrology at the NewYork Presbyterian Hospital-Cornell.  

 Dr. Muthukumar is actively involved in research that is primarily focused on the molecular aspects of transplant rejection and biomarkers. He has published extensively in this area and is supported by grants from the National Institutes of Health and from the American Society of Transplantation. He also received advanced training in clinical and translational research and graduated from the Weill Cornell Graduate School of Medical Sciences with a master's degree in clinical and translational investigation. Dr. Muthukumar serves as an ad hoc member of the NIH study section. He is a Fellow of the American Society of Transplantation (FAST) and the American Society of Nephrology (FASN). In 2017, he was elected as a member of the American Society for Clinical Investigation (ASCI), one of the oldest and most respected medical honor societies in the United States.

 Dr. Muthukumar is board certified in internal medicine and nephrology. He is an Associate Attending Physician at the NewYork-Presbyterian Hospital. He also serves as a nephrology consultant at the Memorial Sloan Kettering Cancer Center and at the Hospital for Special Surgery. He has experience in all facets of nephrology, hypertension, and transplantation medicine, and is especially interested in continuing to advance the field of kidney transplantation and kidney diseases in bone marrow and stem cell transplantation.